Scarica l'app Stockscreener
0.5783
3.29%
-0.0197
Dopo l'orario di chiusura:
.58
0.0017
+0.29%
Sangamo Therapeutics Inc Azioni (SGMO) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
184.39%
18.31
|
6.437 | 7.551 | 49.41 | 0.356 |
Operating Expenses
|
0.27%
36.16
|
36.06 | 33.54 | 38.78 | 37.44 |
| Benefits Costs and Expenses |
3.66%
38.27
|
36.91 | 31.37 | 38.65 | 36.41 |
| Costs And Expenses |
3.66%
38.27
|
36.91 | 31.37 | 38.65 | 36.41 |
| Operating Income/Loss |
39.74%
-17.86
|
-29.63 | -25.99 | 10.63 | -37.08 |
| Income/Loss From Continuing Operations Before Tax |
34.51%
-19.96
|
-30.48 | -23.82 | 10.76 | -36.05 |
| Income Tax Expense/Benefit |
77.31%
0.027
|
0.119 | -0.427 | 0.088 | 0.074 |
| Income/Loss From Continuing Operations After Tax |
34.68%
-19.99
|
-30.60 | -23.40 | 10.67 | -36.13 |
|
Net Income/Loss
|
34.68%
-19.99
|
-30.60 | -23.40 | 10.67 | -36.13 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | 1.287 | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
16.65%
256.95
|
220.27 | 2.85 | 208.34 | 203.95 |
| Diluted Average Shares |
16.65%
256.95
|
220.27 | 2.85 | 214.32 | 203.95 |
| Basic Earnings Per Share |
42.86%
-0.08
|
-0.14 | -0.12 | 0.05 | -0.18 |
| Diluted Earnings Per Share |
42.86%
-0.08
|
-0.14 | -0.12 | 0.04 | -0.18 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | 2.574 | - |
0.64%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):